Cargando…
Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer
BACKGROUND: Prostate cancer (PCa) is the most common type of cancer in men. Destruction of or blocking lipid metabolism impairs the growth, proliferation, and survival of tumor cells. Recent studies on hepatic steatosis suggest that kinase tethers histone-lysine N-methyltransferase 2D (KMT2D) to per...
Autores principales: | Zhai, Qiliang, Luo, Mayao, Zhang, Yifan, Zhang, Wenqiang, Wu, Chenwei, Lv, Shidong, Wei, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459503/ https://www.ncbi.nlm.nih.gov/pubmed/36093518 http://dx.doi.org/10.21037/tcr-22-431 |
Ejemplares similares
-
Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4
por: Lv, Shidong, et al.
Publicado: (2017) -
Tautomycin and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer
por: Luo, Mayao, et al.
Publicado: (2022) -
CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate Cancer
por: Alebady, Zainab A. H., et al.
Publicado: (2023) -
Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer
por: Ding, Beichen, et al.
Publicado: (2019) -
Histone methyltransferase KMT2D contributes to the protection of myocardial ischemic injury
por: Liu, Shu-Bao, et al.
Publicado: (2022)